Prescription Digital Therapeutics

January 18th 2024

The digital prescription therapeutic AspyreRx, when added to prescription diabetes therapies, can help reduce the costs of managing the disease.

January 16th 2024

The smartphone app is currently under investigation in the CONVOKE study as a pharmaceutical therapy, aiming to address the negative symptoms associated with adult schizophrenia.

December 21st 2023

As the only FDA-approved, game-based digital therapeutic, EndeavorRx’s eligibility is expected to more than double the number of pediatric patients with ADHD who have a prescription from a healthcare provider, due to the increased age range.

December 8th 2023

In response to the high demand for healthcare professionals and over 2 million annual job openings — a 40% growth rate surpassing the average for all other occupations—healthcare organizations are seeking technological solutions to address this pressing issue.